BioCentury
ARTICLE | Financial News

Proteomics company Seer launches with $36M

December 21, 2018 7:37 PM UTC

Counting nanoparticle pioneer Omid Farokhzad, Robert Langer and Biogen Inc. (NASDAQ:BIIB) vet Philip Ma among its founders, proteomic data company Seer Inc. (South San Francisco, Calif.) launched on Dec. 17 to develop liquid biopsy tests for early detection of multiple cancers and neurological diseases.

The company raised a total of $36 million in a series A round led by Maverick Ventures and a series B round led by Invus; additional investors were not disclosed...